Pharmaco - Press Releases

Date	Title	Company
02-Dec-2020	Obiltoxaximab Receives Marketing Authorization From European Commission For The Treatment Of Inhalation Anthrax	Elusys Therapeutics, Inc.
02-Dec-2020	Apotex Corp. names new Presdient & Chief Executive Officer	Apotex Corp.
02-Dec-2020	AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets	AbbVie
02-Dec-2020	Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis	Insmed Incorporated
02-Dec-2020	Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms	Abbott
02-Dec-2020	BioInnovation Institute takes in new cohort of promising early-stage innovations	BII
01-Dec-2020	Thomas Biegi Joins MorphoSys as Head of Corporate Communications	MorphoSys AG
01-Dec-2020	Portal Innovations Launching Lab Space at the Fulton Labs Campus One Year Ahead of Schedule	Portal Innovations
01-Dec-2020	Eisai To Present New Seizure Freedom And Real-World Clinical Practice Data Evaluating FYCOMPA® Across Diverse Patient Types At Upcoming AES 2020 Annual Meeting	Eisai Inc.
01-Dec-2020	Cytel Acquires HEOR Experts Purple Squirrel Economics	Cytel Inc.
01-Dec-2020	DR. JUERGEN BECK WILL LEAVE THE PAION AG MANAGEMENT BOARD ON 31 DECEMBER 2020 AS PLANNED	PAION AG
01-Dec-2020	Panaxia continues its upward trend: Ends Q3 with record revenues of 16.8 million and 300% growth over the previous year	Panaxia Pharmaceutical Industries
01-Dec-2020	Medartis announces strategic partnership with KeriMedical	Medartis Holding AG
30-Nov-2020	PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia	PTC Therapeutics, Inc.
30-Nov-2020	Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis	ABIVAX
30-Nov-2020	M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG - Group	M1 Kliniken AG
30-Nov-2020	HAEMATO AG: Expansion of the board of directors: Strengthening the strategic and operative implementa-tion of the product business in the Haemato Group	HAEMATO AG
30-Nov-2020	Elevar Therapeutics Appoints Gus Aromin as Vice President of Regulatory Affairs	Elevar Therapeutics
30-Nov-2020	Post-Hoc Analysis of ALS Treatment Study Looks at Multiple Staging Systems	Mitsubishi Tanabe Pharma America, Inc.
30-Nov-2020	Generis Partner with Cognizant to Deliver Innovative Information Management and Structured Content Authoring Solutions to the Life Sciences	Generis